Home / Sitagliptin / Canada
CA ATC A10BH01 · updated 2 Nov 2026
Sitagliptin shortage in Canada
Is there a Sitagliptin shortage in Canada?
Yes. As of 2 Nov 2026, 16 Sitagliptin products are reported short in Canada, the first since 20 Mar 2024. No return date has been given. Main reason: manufacturing problem.
Also short in Italy, Spain, Ireland, Austria, Czechia, Sweden, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | ACH-SITAGLIPTIN (90) | ACCORD HEALTHCARE INC | 20 Mar 2024 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | ACH-SITAGLIPTIN (30) | ACCORD HEALTHCARE INC | 28 Jun 2024 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | ACH-SITAGLIPTIN (30) | ACCORD HEALTHCARE INC | 28 Jun 2024 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | TEVA-SITAGLIPTIN MALATE (30 & 100) | TEVA CANADA LIMITED | 5 Mar 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-SITAGLIPTIN MALATE (30 & 100) | TEVA CANADA LIMITED | 5 Mar 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-SITAGLIPTIN MALATE (30 &100) | TEVA CANADA LIMITED | 5 Mar 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-SITAGLIPTIN MALATE (500 BTL) | APOTEX INC | 12 Aug 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-SITAGLIPTIN MALATE (100 BTL) | APOTEX INC | 14 Oct 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-SITAGLIPTIN MALATE (100 BTL) | APOTEX INC | 14 Oct 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-SITAGLIPTIN MALATE (30 BTL) | APOTEX INC | 14 Oct 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-SITAGLIPTIN MALATE (30 BTL) | APOTEX INC | 14 Oct 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-SITAGLIPTIN MALATE (100 BTL) | APOTEX INC | 4 Nov 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-SITAGLIPTIN MALATE (30 BTL) | APOTEX INC | 18 Nov 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PRO-SITAGLIPTIN MALATE (30;100) discontinuation | PRO DOC LIMITEE | not given | not given | Not stated |
| CA | PRO-SITAGLIPTIN MALATE (30;100) discontinuation | PRO DOC LIMITEE | not given | not given | Not stated |
| CA | PRO-SITAGLIPTIN MALATE (30;100;500) discontinuation | PRO DOC LIMITEE | not given | not given | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.